Activated protein C cleaves factors Va and VIIIa, thereby inhibiting the blood clotting process. Any of several mutations of factor V causes its resistance to activated protein C, thereby increasing the susceptibility to thrombosis. The most common mutation of factor V is the Leiden mutation. Homozygous mutations increase the risk of thrombosis to a greater extent than heterozygous mutations.